Five Prime Therapeutics, Inc. Total Assets
Five Prime Therapeutics, Inc. had Total Assets of $331.65 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2021-03-22
- 2020-12-31: Assets $331.65M.
- 2020-09-30: Assets $160.38M.
- 2020-06-30: Assets $185.34M.
- 2020-03-31: Assets $202.97M.
| Period end | Assets |
|---|---|
| 2020-12-31 | $331.65M 10-K · filed 2021-03-22 |
| 2020-09-30 | $160.38M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $185.34M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $202.97M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $224.14M 10-K · filed 2021-03-22 |
| 2019-09-30 | $258.54M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $292.91M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $315.76M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $321.53M 10-K · filed 2020-02-27 |
| 2018-09-30 | $366.36M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $396.78M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $436.71M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $344.05M 10-K · filed 2019-02-26 |
| 2017-09-30 | $357.42M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $380.11M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $409.08M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $448.28M 10-K · filed 2018-02-27 |
| 2016-09-30 | $465.13M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $497.77M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $509.26M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $548.28M 10-K · filed 2017-02-24 |
| 2015-09-30 | $194.97M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $215.52M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $224.57M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $155.63M 10-K · filed 2016-03-11 |
| 2014-09-30 | $136.26M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $146.41M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $154.31M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $81.79M 10-K · filed 2015-03-18 |
| 2013-09-30 | $92.05M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $44.09M 10-K · filed 2014-03-26 |